What Did This CEO Just Do with Personal Shares of Natus Medical Inc. (NASDAQ: BABY)?

By George MacDonald

Yesterday, the President & CEO of Natus Medical Inc. (NASDAQ: BABY), James Hawkins, sold shares of BABY for $2.82M.

Following James Hawkins’ last BABY Sell transaction on November 12, 2015, the stock climbed by 2.0%. In addition to James Hawkins, one other BABY executive reported Sell trades in the last month.

Based on Natus Medical Inc.`s latest earnings report from September 30, the company posted quarterly revenue of $94.58M and quarterly net profit of $10.93M. In comparison, last year the company earned revenue of $89.88M and had a net profit of $7.79M. The company has a one year high of $49.72 and a one year low of $29.34. BABY’s market cap is $1.61B and the company has a P/E ratio of 40.6%.

Looking at blogger coverage of BABY, there is a 100% Bullish tendency on the stock, in relation to an 80% average bullish tendency within the Healthcare sector.

Over the last 3 months, the insider sentiment on Natus Medical Inc. has been negative based on 38 corporate insider transactions. This sentiment is lower than the average sector sentiment of insiders.

Natus Medical Inc provides newborn care & neurology healthcare products & services used for screening, diagnosis, detection, treatment, monitoring & tracking of medical ailments in newborn care, epilepsy, sleep disorders, and balance & mobility disorders.